Drug Profile
Research programme: gap junction modulators - Zealand Pharma
Alternative Names: ZP 1210Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Zealand Pharma
- Developer Pfizer; Zealand Pharma
- Class Small molecules
- Mechanism of Action Gap junction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders